Gene interactions and pathways from curated databases and text-mining

◀ Back to HDAC3

CDK19 — HDAC3

Pathways - manually collected, often from reviews:

Text-mined interactions from Literome

Trivedi et al., J Biol Chem 2008 (Cardiomegaly...) : Hdac3 overexpression inhibits several cyclin dependent kinase inhibitors, including Cdkn1a, Cdkn1b, Cdkn1c, Cdkn2b, and Cdkn2c
Veliz et al., Cancer Control 2012 (Leukemia, Lymphocytic, Chronic, B-Cell...) : These investigational agents include rituximab, alemtuzumab, ofatumumab, bendamustine, high-dose methylprednisolone, lenalidomide, lumiliximab, cyclin dependent kinase inhibitors, small modular immunopharmaceuticals, Bcl-2 inhibitors, and histone deacetylase inhibitors